9^th Annual Congress on Endocrine Disorders and Therapies October 30-31, 2017
(10 Plenary Forums - 1 Event)
Chicago, Illinois, USA

With enthusiastic support of our Organizing Committee and Editorial Board Member, it’s my pleasure to welcome you to participate in the 9th Annual Congress on Endocrine Disorders as a continuum of our previous successful conference, in Chicago, Illinois USA, on October 30- November 1, 2017.

Track 1: Endocrine Disorders

Endocrine system is a network of glands that produce and release hormones that help control many important body functions, including the body's ability to change calories into energy that powers cells and organs. The endocrine system influences how your heart beats, how your bones and tissues grow, even your ability to make a baby. It plays a vital role in whether or not you develop diabetes, thyroid disease, growth disorders, sexual dysfunction, and a host of other hormone-related disorders. Each gland of the endocrine system releases specific hormones into your bloodstream. These hormones travel through your blood to other cells and help control or coordinate many body processes.

Related Conferences:

9^th Global Congress on Endocrine Disorders and Therapies, August 21-22 2017, Toronto, Canada; 16th Global Diabetes Conference and Medicare Expo, March 22-23, 2017  Rome, Italy; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Tapei, Taiwan; 25th Global Diabetes Summit and Medicare Expo, July 17-18, 2017 ,Dubai UAE; 18th European Diabetes Congress, January 14 - 15, 2017 Lisbon, Portugal; Advances in Medical and Surgical Management of Thyroid Cancer Tampa; 53rd Annual Clinical Diabetes and Endocrinology Aspen/Snowmass, January 21 - 24, 2017  USA; Keystone Symposium on Obesity and Adipose Tissue Biology Keystone, January 22 - 26, 2017, Colorado, USA

Track 2: Hormones & Steroids

Hormones are chemical messengers that have diverse chemical structures including eicosanoids, steroids, amino acid derivatives, peptides, and proteins that are secreted into the blood, which carries them to organs and tissues of the body to exert their functions. They are essential for every activity of life, including the processes of such as digestion, metabolism, respiration, tissue function, sensory perception, sleep, excretion, lactation, stress, growth and development, movement, reproduction, and mood. Many hormones, such as neurotransmitters, are active in more than one physical process.

Related Conferences: 

9^th Global Congress on Endocrine Disorders and Therapies July 20-22, 2017 Toronto, Canada; 19th Asia Pacific Diabetes Conference, August 21-22 2017 Melbourne, Australia; 20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 3^rd Global Summit on Hormones And Steroids August 28-30, 2017  Houston, USA; 2^nd International Conference On Metabolic Syndrome August 10-11,2017, London,UK; 18th European Diabetes Congress July 17-18, 2017, Lisbon, Portugal; Keystone Symposium on Diabetes Keystone, January 22 - 26, 2017 Colorado, USA; Keystone Symposium on Bile Acid Receptors As Signal Integrators in Liver And Metabolism Monterey, March 3 - 7, 2017 , California, USA;  Metabolic Syndrome Bench To Clinic Baltimore, March 11, 2017 , USA; Gordon Research Conference On Igf and Insulin System in Physiology and Disease Ventura, March 12 - 17,2017, USA

Track 3: Endocrinology and Obesity

Obesity is highly associated with various endocrine abnormalities that are characterized by hormonal imbalance and/or resistance. Weight reduction generally normalizes these endocrine alterations, implicating obesity as a direct cause. Being overweight or obese predisposes an individual to many medical problems including diabetes, high blood pressure, heart disease, stroke, depression and some types of cancer. In the United States, the frequency of these conditions is increasing at epidemic rates.

Related Conferences

9^th Global Congress on Endocrine Disorders and Therapies, August 24-25 2017, Toronto, Canada; International Conference on Diabetes September 20-22, 2017, Denver, USA; 22nd International Congress on Prevention of Diabetes and Complications October 05-06, 2017 , London, UK; 14th Global Diabetes Conference And Medicare Expo march 22-23, 2017 Rome, Italy; 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders, November 2-4, 2017,  Bangkok, Thailand; 1st International Congress of Kuwait Endocrine Society, March 16 - 18, 2017 Kuwait;  Sex and Gender Factors affecting Metabolic Homeostasis and Diabetes and Obesity, March 19-23, 2017 Tahoe City; World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases March 23 - 26, 2017 Florence; The 2017 Rachmiel Levine Arthur Riggs Diabetes Research Symposium March 28 - 31, 2017  Orlando, USA.

Track 4: Cushing's disease

Overproduction of a pituitary gland hormone leads to an overactive adrenal gland. A similar condition called Cushing's syndrome may occur in people, particularly children, who take high doses of corticosteroid medications. It is a cause of Cushing's syndrome characterized by increased secretion of adrenocorticotropic hormone (ACTH) from the anterior pituitary. This is most often as a result of a pituitary adenoma  or due to excess production of hypothalamus CRH  that stimulates the synthesis of cortisol by the adrenal glands. Pituitary adenomas are responsible for 80% of endogenous Cushing's syndrome, when excluding Cushing's syndrome from exogenously administered corticosteroids.

Related Conferences:

9^th Global Congress on Endocrine Disorders and Therapies August 21-22 2017, Toronto, Canada; 15th International Conference on Targeting Diabetes and Novel Therapeutics November 6-8, 2017  Madrid, Spain; Diabetes, Metabolism & Obesity November 16-17, 2017 Las Vegas, USA; 10th International Conference on Endocrionology December 06-08, 2017  Atlanta, USA; 10th International Conference on Childhood Obesity And Nutrition June 12-13, 2017 Rome, Italy; 12th Obesity And Endocrinology Congress July 17-19, 2017  Melbourne, Australia; 12th World Congress on Obesity August 24-25, 2017 Toronto, Canada; 13th Euro Obesity and Endocrinology Congress, September 21-22, 2017 Zurich, Switzerland; Enocrine Fellow Series: Type 1 Diabetes and Type 2 Diabetes March 29 - 30, 2017  Orlando, USA; 15th International Pituitary Congress Orlando, USA; The 3rd World Conference On Kisspeptin, March 30 - 31, 2017  Orlando, USA

Track 5: Gigantism and Growth Hormone Disorders

Overproduction of growth hormone causes excessive growth. In children, the condition is called gigantism. In adults, it is called acromegaly. Growth hormone stimulates the growth of bones, muscles, and many internal organs. Excessive growth hormone, therefore, leads to abnormally robust growth of all of these tissues. Overproduction of growth hormone is almost always caused by a noncancerous (benign) pituitary tumor (adenoma). Certain rare tumors of the pancreas and lungs also can produce hormones that stimulate the pituitary to produce excessive amounts of growth hormone, with similar consequences.

Related Conferences:

9^th Global Congress Endocrine Disorders and Therapies, August 21-22 2017 Toronto,Canada; 16th International Conference And Exhibition on Obesity & Weight Management, November 13 -14, 2017  Atlanta, USA; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taipei, Taiwan; 16th International Conference and Exhibition on Obesity & Weight Management November 13 -14, 2017 Atlanta, USA; 2nd International Conference on Genetic Counselling and Genomic Medicine April 24-26, 2017, Las Vegas, USA; Androgen Excess And Pcos Society Update Meeting March 31, 2017, Orlando, USA; American Thyroid Association Spring 2017 Satellite Symposium Hypothyroidism March 31, 2017,Orlando,  USA.

Track 6: Hypothyroidism and Hyperthyroidism

The thyroid gland does not produce enough thyroid hormone, leading to fatigue, constipation, dry skin, and depression. The underactive gland can cause slowed development in children. Some types of hypothyroidism are present at birth. Hypothyroidism can be treated with levothyroxine. The dose is adjusted according to symptoms and normalization of the thyroxine and TSH levels. Thyroid medication is safe in pregnancy. While a certain amount of dietary iodine is important, excessive amounts can worsen certain types of hypothyroidism.

Related Conferences:                          

9^th Global Congress on Endocrine Disorders and Therapies August 21-22 2017 Toronto, Canada; 10th International Conference on Childhood Obesity and Nutrition June 12-13, 2017,Rome, Italy; 25th Global Diabetes Summit and Medicare Expo December 11-12,2017, Dubai; 3rd World Congress on Polycystic Ovarian Syndrome November 02-04, 2017, San Antonio, USA; 16th International Conference and Exhibition on Obesity & Weight Management November 13 -14, 2017, Atlanta, USA; 13th Euro Obesity and Endocrinology Congress, September 21-22, 2017, Zurich, Switzerland; The 5th Seoul International Congress of Endocrinology and Metabolism;  April 27 - 30, 2017, Seoul, South Korea;  Frontiers in Reproduction Woods Hole, Massachusetts, April 29 - June 17 USA; Keystone Symposium on Neuronal Control of Appetite and Metabolism and Weight May 9 - 13, 2017 ,Copenhagen, Denmark.

Track 7 : Multiple endocrine neoplasia I and II

These are rare, genetic conditions are passed down through families. They cause tumors of the parathyroid, adrenal, and thyroid glands, leading to overproduction of hormones. The cause of MEN II is a defect in a gene called RET. This defect causes many tumors to appear in the same person, but not necessarily at the same time. The disorder may occur at any age, and affects men and women equally. The main risk factor is a family history of MEN II.

Related Conferences:

9^th Global Congress Endocrine Disorders and Therapies, August 21-22 2017 Toronto,Canada; 16th International Conference And Exhibition on Obesity & Weight Management, November 13 -14, 2017  Atlanta, USA; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taipei, Taiwan; 16th International Conference and Exhibition on Obesity & Weight Management November 13 -14, 2017 Atlanta, USA; 2nd International Conference on Genetic Counselling and Genomic Medicine April 24-26, 2017, Las Vegas, USA; Androgen Excess And Pcos Society Update Meeting March 31, 2017, Orlando, USA; American Thyroid Association Spring 2017 Satellite Symposium Hypothyroidism March 31, 2017,Orlando,  USA.

Track 8: Polycystic Ovary Syndrome

Overproduction of androgens interfere with the development of eggs and their release from the female ovaries. PCOS is a leading cause of infertility. Polycystic ovary syndrome is a problem in which a woman hormones are out of balance. It can cause problems with your periods and make it difficult to get pregnant. PCOS also may cause unwanted changes in the way you look. If it isn't treated, over time it can lead to serious health problems, such as diabetes and heart disease. Hormones are chemical messengers that trigger many different processes, including growth and energy production. Often, the job of one hormone is to signal the release of another hormone.

Related Conferences:

9^th Global Congress on Endocrine Disorders and Therapies, August 21-22 2017 Toronto Canada; 10th International Conference on Childhood Obesity and Nutrition June 12-13, 2017, Rome, Italy; 2nd International Conference on Pancreatic Disorders and Treatment September 13-14, 2017 Dallas, USA; 2nd World Summit on Metabolic Disorders October 16-18, 2017  Chicago, USA; 2nd International Conference on Digestive Diseases October 16-17, 2017, London, UK; 4th International Conference on Hepatology April 27-28, 2017, Dubai, UAE; 4th International Conference on Clinical Case Reports January 17-19, 2017, Dubai,UAE; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taipei, Taiwan; 16th Global Diabetes Conference And Medicare Expo Rome, Italy; The 7th Ivi International Congress May 11 - 13, 2017,Bilbao, Spain;  19th European Congress of Endocrinology May 20 - 23, 2017 Lisbon; 8th International Conference on Childrens Bone Health June 10 - 13, 2017,Würzburg, Germany.

Track 9: Pituitary Disorders and Pituitary Tumors

The most frequent type of pituitary disorder is a pituitary gland tumor. These tumors are fairly common in adults. They are not brain tumors and are almost always benign. Not all pituitary tumors cause symptoms. Pituitary tumors that make hormones can cause a variety of signs and symptoms depending on the hormone they produce. The signs and symptoms of pituitary tumors that don't make hormones are related to their growth and the pressure they put on other structures.

The pituitary is the "master control gland" - it makes hormones that affect growth and the functions of other glands in the body. With pituitary disorders, you often have too much or too little of one of your hormones. Injuries can cause pituitary disorders, but the most common cause is a pituitary tumor. Pituitary gland disorders can affect many different parts of the body.  Conditions such as acromegaly, Cushing's syndrome, hypothyroidism, and hypogonadism all may result from pituitary gland disease.

Related Conferences:

9^th Global Congress on Endocrine Disorders and Therapies August 21-22 2017 Toronto,Canada; 16th Global Diabetes Conference and Medicare Expo December 11-12, 2017, Rome, Italy; 25th Global Diabetes Summit and Medicare Expo Dubai, UAE; 18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; 4^th International Conference on Blood Malignancies And Treatment April 18-20 2017, UAE;  19th Asia Pacific Diabetes Conference July 20-22, 2017 Melbourne, Australia;  10th International Conference on Childhood Obesity and Nutrition June 12-13, 2017, Rome, Italy; 19th Asia Pacific Diabetes Conference August 2 - 3, 2017 Melbourne, Victoria, Australia

Track 10: Sex Hormone Disorders

Sex hormone disorders occur when there is either an overproduction or underproduction of the hormones responsible for sexual characteristics and development. In females, the main female hormone is estrogen which is primarily produced by the ovaries. Women also produce androgens. Testosterone and DHEAS are two of the androgens women produce. When these hormones are not in balance women may experience symptoms including menstrual cycle irregularities, hirsutism, acne and alopecia. In males, the main male hormone is testosterone. When males do not produce enough testosterone they may experience a decline in libido, erectile dysfunction, loss of muscle and loss of body hair.

Related Conferences

9^th Global Congress on Endocrine Disorders and Therapies August 21-22 2017 Toronto, Canada; 16th Global Diabetes Conference and Medicare Expo March 22-23, 2017,  Rome, Italy; 8th International Conference on Adrenal & Thyroid Disorders, Treatment , June 12-13, 2017 Tapei, Taiwan; 25th Global Diabetes Summit and Medicare Expo December 11-12, 2017 Dubai UAE; 18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; Advances in Medical and Surgical Management of Thyroid Cancer January 14 - 15, 2017 Tampa; 53rd Annual Clinical Diabetes and Endocrinology Aspen/Snowmass January 21 - 24, 2017 USA; Keystone Symposium on Obesity and Adipose Tissue Biology Keystone, January 22 - 26, 2017  Colorado,USA.

Track 11: Diabetes and Metabolic Syndrome

The metabolic syndrome is a cluster of the most dangerous heart attack risk factors: diabetes and prediabetes, abdominal obesity, high cholesterol and high blood pressure. People with metabolic syndrome are twice as likely to die from, and three times as likely to have a heart attack or stroke compared with people without the syndrome. People with metabolic syndrome have a five-fold greater risk of developing type 2 diabetes. Up to 80% of the 200 million people with diabetes globally will die of cardiovascular disease. This puts metabolic syndrome and diabetes way ahead of HIV/AIDS in morbidity and mortality terms yet the problem is not as well recognised.

Related Conferences:

9^th Global Congress on Endocrine Disorders and Therapies August 24-25 2017 Toronto, Canada; 20th World Summit on Diabetes, Nutrition, Metabolisim and Medicare July 24-26,2017  Vancouver, Canada;  3rd Global Summit On Hormones and Steroids August 28-30, 2017  Houston, USA; International Conference on Diabetes September 20-22, 2017 Denver, USA; 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders November 2-4, 2017 Bangkok, Thailand; Endocrine Fellows Series: Osteoporosis and Metabolic Bone Diseases August 2 - 3, 2017, Santa Fe, New Mexico,USA; World Congress on Osteoporosis Osteoarthritis and Musculoskeletal Diseases Krakow 2018 April 19 - 22, 2018 Krakow, Poland.

Track 12: Endocrine Hypertension and Related Syndromes

Hypertension is caused due to the elevation in the blood pressure levels which is defined as systolic blood pressure >140 mm Hg. Endocrine hypertension is the raise of hypertension caused by the imbalance of hormones. This frequently involves the pituitary or adrenal gland. The person who is more likely to have hypertension before the age of 30 with a strong family history of adrenal gland tumors , hypertension or develop hypokalemia should undergo endocrine hypertension screening. the endocrine hypertension can be caused due to the over or less production of hormone or when effected by tumors.

Related Conferences:

9^th Global Congress and Endocrine Disorders and Therapies, August 21-22 2017 Toronto Canada; 10th International Conference on Childhood Obesity and Nutrition June 12-13, 2017, Rome, Italy; 2nd International Conference on Pancreatic Disorders and Treatment September 13-14, 2017 Dallas, USA; 2nd World Summit on Metabolic Disorders October 16-18, 2017  Chicago, USA; 2nd International Conference on Digestive Diseases, October 16-17, 2017, London, UK; 4th International Conference on Hepatology April 27-28, 2017, Dubai, UAE; April 4th International Conference on Clinical Case Reports, January 17-19, 2017, Dubai,UAE; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taipei, Taiwan; 16th Global Diabetes Conference and Medicare Expo Rome, Italy; The 7th Ivi International Congress May 11 - 13, 2017, Bilbao, Spain; 19th European Congress of Endocrinology May 20 - 23, 2017 Lisbon; 8th International Conference On Childrens Bone Health June 10 - 13, 2017,Würzburg, Germany.

Track 13 Adrenoleukodystrophy or Adrenomyeloneuropathy

Adrenoleukodystrophy also known as ALD is a genetic disease or an inborn error of metabolism that affects 1 in 18000 people today. This is also known as X linked adrenoleukodystrophy as it is linked to x chromosome. This is a brain disorder that is caused due to the building up of fatty acids which are caused by the enzymes which do not function properly. This results in the destruction of the myelin sheath which is known as a protective sheath that surrounds the neurons in the brain. The destruction of the myelin sheath results in hyperactivity and seizures and also dyslexia. It’s a disorder of peroxisomal fatty acid beta oxidation which results in the accumulation of long fatty acid chains in the body. The adrenal cortex and leydig cells in the testes are also effected. The treatment options for ALD are very limited. Dietary therapy is done by Lorenzo oil. If the defect is spotted in the childhood treatment can be done by stem cell transplant and gene therapy.

Related Conferences:

9^th Global Congress on Endocrine Disorders and Therapies July 20-22, 2017 Toronto, Canada; 19th Asia Pacific Diabetes Conference August 21-22 2017 Melbourne, Australia; 20th World Summit on Diabetes, Nutrition, Metabolism & Medicare July 24-26,2017 Vancouver, Canada; 3^rd Global Summit on Hormones and Steroids August 28-30, 2017  Houston, USA; 2^nd International Conference on Metabolic Syndrome August 10-11,2017, London,UK; 18th European Diabetes Congress July 17-18, 2017, Lisbon, Portugal; Keystone Symposium on Diabetes Keystone, January 22 - 26, 2017 Colorado, USA; Keystone Symposium on Bile Acid Receptors As Signal Integrators in Liver and Metabolism Monterey, March 3 - 7, 2017 , California, USA;  Metabolic Syndrome Bench to Clinic Baltimore, USA, March 11, 2017 , United States Minor Outlying Islands; Gordon Research Conference On Igf and Insulin System in Physiology and Disease Ventura, March 12 - 17,2017 , CA, USA

Track 14: Cryptorchidism

Cryptorchidism is the highly common genital problem that is encountered in pediatrics. This is detected by the absence of one or both testes from the scrotum and generally refers to an undescended or maldescended testis. About 3% of full-term and 30% of premature infant boys are born with at least one undescended testis. This may develop after the infant stage or during the late adulthood ( but this is exceptional ). Cryptorchidism is a from of monorchism, the condition of having only one testicle. The condition may occur on one or both sides; it more commonly affects the right testis.. cryptorchidism nearly always refers to congenital absence or maldescent, a testis observed in the scrotum in early infancy can occasionally "reascend" into the inguinal canal.

Related Conferences:

9^th Global Congress on Endocrine Disorders and Therapies August 21-22 2017 Toronto,Canada; 16th International Conference and Exhibition on Obesity & Weight Management, November 13 -14, 2017  Atlanta, USA; 8th International Conference on Adrenal & Thyroid Disorders, Treatment June 12-13, 2017 Taipei, Taiwan; 16th International Conference and Exhibition on Obesity & Weight Management November 13 -14, 2017 Atlanta, USA; 2nd International Conference on Genetic Counselling and Genomic Medicine April 24-26, 2017, Las Vegas, USA; Androgen Excess and Pcos Society Update Meeting march 31, 2017, Orlando, USA; American Thyroid Association Spring 2017 Satellite Symposium Hypothyroidism March 31, 2017,Orlando, Florida, USA.

Track 15: Thyroid Cancer

Thyroid cancer is a tumorous condition that arises when abnormal cells begin to grow in the thyroid gland. The gland resembles a butterfly shape located infront of the neck. This is originated from follicular and parafollicular cells. This can be detected in the early stage and can be cured in the early stage. This cancer may revert back after the treatment after many years or immediately. The causes are detected as the changes in the DNA in the cells that are likely to inherit from one generation to the other generation. The malignant tumors can be removed by a process known as thyroidectomy followed by the radioactive iodine ablation and TSH suppression therapy. Chemotherapy or radiotherapy can also be done during the metastasis stage or the advanced cancer stage

Related Conferences:

9^th Global Congress on Endocrine Disorders and Therapies August 24-25 2017 Toronto, Canada; 20th World Summit on Diabetes, Nutrition, Metabolisim and Medicare July 24-26,2017  Vancouver, Canada;  3rd global Summit on Hormones and Steroids August 28-30, 2017  Houston, USA; International Conference on Diabetes September 20-22, 2017 Denver, USA; 23rd International Conference on Herbal and Alternative Remedies for Diabetes and Endocrine Disorders November 2-4, 2017  Bangkok, Thailand; Endocrine Fellows Series: Osteoporosis and Metabolic Bone Diseases August 2 - 3, 2017,2017 Santa Fe, New Mexico,USA;  Endobridge October 19 - 22, 2017 Antalya, Turkey; World Congress on Osteoporosis Osteoarthritis and Musculoskeletal Diseases Krakow 2018 April 19 - 22, 2018 Krakow, Poland.

Track 16: Neuroendocrine Disorders

Neuroendocrine cancer is a malignant tumour that starts in neuroendocrine cells. Neuroendocrine tumors most commonly occur in the intestine, where they are often called carcinoma tumors.  Pancreatic neuroendocrine tumors form in hormone-making cells (islet cells) of the pancreas. They may or may not cause signs or symptoms. Neuroendocrine small cell cancer accounts for approximately 15% of bronchogenic carcinomas.

Related Conferences:

9^th Global Congress on Endocrine Disorders and Therapies August 21-22 2017 Toronto, Canada; 16th Global Diabetes Conference and Medicare Expo March 22-23, 2017,  Rome, Italy; 8th International Conference on Adrenal & Thyroid Disorders, Treatment , June 12-13, 2017 Tapei, Taiwan; 25th Global Diabetes Summit and Medicare Expo December 11-12, 2017 Dubai UAE; 18th European Diabetes Congress July 17-18, 2017 Lisbon, Portugal; Advances in Medical and Surgical Management of Thyroid Cancer January 14 - 15, 2017 Tampa; 53rd Annual Clinical Diabetes and Endocrinology Aspen/Snowmass January 21 - 24, 2017 USA; Keystone Symposium on Obesity and Adipose Tissue Biology Keystone, January 22 - 26, 2017  Colorado,USA.

With this enthusiastic support of our Organizing Committee and Editorial Board Member, we are overwhelmed to announce 9^th Annual Congress on Endocrine Disorders and Therapies as a continuum of our previous successful conference. Endocrine disorders and therapies 2017 will be held in Chicago, Illinois USA on October 30- November 1st, 2017. The conference  will focus on Collaborative Strategies and Innovative Approaches to fight Endocrine Disorders.

This conference includes the renowned scientists, geneticist, endocrinologists doctors, professors, public health planners, physicians, dietitians, pharmacists, students under the research of endocrine disorders and therapies. Industrial delegates and those using bioinformatics tools for studying under the single roof to discuss and for improving the current therapies, and exploring radical new approaches. The event offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions, workshop, symposium etc.

For more details, please visit: http://endocrine.conferenceseries.com/

Scope and Importance of Endocrine Disorders and Therapies

Endocrine disorders are the major field in the medical technology today.  Endocrine disorders are diseases that are related to the endocrine glands in the body.  There are major organelles in the system which produce hormones that regulate the major growth and metabolism of the body such as appetite, breathing, growth, fluid balance, feminization and virilization, and weight control. These are caused either by the low production or the excessive production of hormones which imbalances the body functions. 54 disorders are included by clinical and public health significance. Endocrine disorders  are estimated to have 5% prevalence in the adults of USA with common disorders such as diabetes mellitus, Impaired glucose tolerance, obesity, osteoporosis etc. these were found to be present in many of men and women in 2017. When the researchers from the Brussels university tested 1900 women during the first three months of their pregnancy in 2016 they found that atleast 35% were low on iron. Among them, 20% had hypothyroidism and 10% had fluctuated levels of thyroid perioxidase antibodies., 16% of women were detected with normal iron levels had low thyroid function and 6% had high thyroid antibody levels. Many of the scientists are reporting tests from wealthy countries found iron deficiency as the major problem for endocrine disorders to raise in 2016

The management of endocrine diseases require a huge understanding of intermediary metabolism of the body such as reproductive physiology, bone growth and metabolism and growth of the body.  The endocrine system is examined primarily by clinical and valuable diagnostic information. These disorders are treated with hormone replacement, dietary therapies, gene therapy or by the surgical removal of glandular tumors , by reducing the hormone levels by taking medications. Hormone replacement is widely used for the treatment of endocrine disorders now a days. Hormone therapy took an important place since many years till today for treating childhood endocrine diseases. The replacement of sex hormones also plays an important role in proper functioning of sexual glands which is also known as replacement therapy. There are also different techniques known as stimulation therapy radiation therapies which is commonly known as chemotherapy for the reduction of disorders.

The major therapies which are being used widely today are hormonal therapy, replacement therapy, radiation therapy, hormonal medication, stimulation therapy, gene therapy by following recombination DNA techniques, by surgical removal of tumors, chemotherapy etc. The treatment of endocrine disorders has a great importance this is not only done by the varieties therapy but also following proper eating habits and drinking habits which reduces a major risk of endocrine disorders today world wide and promoting the survival rate by reducing the risk of disease

Why Chicago, USA? (American Region)

More than 29 million adults and children in the United States are living with complications caused by endocrine glands, and it’s estimated  that an additional 86 million Americans ages 20 years or older have metabolic syndromes like diabetes or obesity, putting them at increased risk of developing the disease. One of the Endocrinology Diseases i.e. Diabetes is the seventh leading cause of death in the United States. This will be driven by an increase in the prevalent population due to urbanization, advancement in the lifestyle of the people and by expected drug launches.

In order to prevent the people and make them aware regarding the metabolic diseases and other health complication caused like heart disease, blindness and kidney failure, an international conference is set up at Chicago, USA. Chicago, on Lake Michigan in Illinois, is among the largest cities and thirds most populous City in the U.S and fifth most populous city in North America.

Prevalence of Endocrine Disorders in USA

There has not been a detailed compilation of data linked to the epidemiology of each and every endocrine and metabolic disorders in the United States. reserachers included 54 disorders with clinical and public health significance. Ultimately, they prepared a data from 70 articles. Endocrine disorders with U.S. estimated at least 5% in adults included diabetes mellitus, impaired glucose tolerance, obesity,osteoporosis, osteopenia, mild-moderate hypovitaminosis D, erectile dysfunction, dyslipidemia, and thyroiditis. Erectile dysfunction and osteoporosis had the highest incidence in men and women, respectively. The least prevalent condition is less than 1% of the U.S. population, were diabetes mellitus in children and pituitary adenoma. The disorders with lowest prevalence were adrenocortical carcinoma, pheochromocytoma, and pituitary adenomas. Certain disorders, such as hyperparathyroidism and thyroid disorders, were more common in females. The occurrence of  diabetes mellitus was highest among ethnic minorities. Sparse data were available on pituitary, adrenal, and gonadal disorders. The current review shows that the incidence of common endocrine and metabolic disorders are high in people. Defining the epidemiology of these conditions will provide clues to risk factors and identify areas to allocate public health and research resources.

Societies and Hospitals Associated with Endocrine Disorder Research

To encourage, educate, update and train registered medical practitioners, dieticians, qualified nurses and other appropriately qualified paramedical personnel in the field of Endocrinology and its related Disorders and a various well-known societies/associations are working across the globe to efficiently prevent and combat the fatal disease.

• University of Washington Medical Center (Seattle, WA)
• UCLA Medical Center (Los Angeles, CA)
• Northwestern Memorial Hospital (Chicago, IL)
• Yale-New Haven Hospital (New Haven, CT)
• Johns Hopkins Hospital (Baltimore, MD)
• Massachusetts General Hospital (Boston, MA)
• Mayo Clinic (Rochester, MN)
• Brigham & Womes Hospital
• University of California at Los Angeles
• Johns Hopkins University
• Texas A & M University
• California Institute of Technology – Caltech
• Georgia Institute of Technology
• Stanford University
• Duke University Durham, North Carolina, United States.
• TIC San Diego USA
• University of Pennsylvania
• Washington University School of Medicine
• Virginia University
• The American Association of Endocrine Surgeons
• North American Society for Comparative Endocrinology
• American Association of Clinical Endocrinologists
• International Society of Endocrinology
• American Thyroid Association
• Endocrine Fellows Foundation

Market Value on Endocrine Disorders and Therapy Research:

The global endocrine testing market has a large business share with the top 5 people namely F-hoffman la roche, abbot laboratories, agilent technologies,  diasorin, and siemens healthcare holding about 90% of  market share.  The wide range of products, including lab automation systems, analyzers, next generation sequencing platforms, and endocrine test kits, offered by the company assisted it to reach this position.

The sudden increase in the obesity in the people with endocrine disorders have triggered the adoption of various endocrine testing techniques. Obesity, which has been arising as a major healthcare issue, worldwide, is also providing a huge base to endocrine testing for applications as it results in a number of fatal diseases such as cardiovascular disorders, stroke, hypertension, cancer, and various diseases related to reproductive system. From the above discussion we can see that the demand for endocrine testing is increasing and will increase in upcoming future. The endocrine testing market is expected to exhibit an increased growth in the coming years.

Demand for Endocrine Testing to Remain High in North America

The estimated world wide calculation  for endocrine testing was worth US$6.1 bn in 2015, its likely to raise at CAGR of 8.50% during the time of 2015-2023 and touch a value of US$12.8 by the end of the  period, currently north America is at the higher position in this market and is expected to be at the leading position throughout the period resulting in the share of 38.3% by 2023. On the other hand asia pacific is likely to increase in the CAGR  of 10.3% between the period of 2015-2023. In 2016, thyroid stimulating hormone accounted for the largest market share in terms of revenue. This growth is mainly because of the risein the incidences of thyroid disorders and the growing awareness about the correlation between variations in the thyroid hormones levels and cardiovascular disorders. Insulin test was another key point of the market and is expected to show witness fastest growth in the upcoming future. Europe is also expected to exhibit an equal growth in the upcoming years. This change is mainly because of the increase in the concern towards health. Moreover, increasing demand endocrine testing kits associated with technological advancement is expected to increase the market growth within the expected period.

Global prevalence of the Endocrine Disorder Therapy

Endocrinology is the branch of biology that particularly deals with the study of the endocrine system. The raise  of certain disorders which are related to endocrine disorders such as diabetes, obesity have been well defined in the larger studies. The treatment have improved the living of around 200 million people with thyrioid disease around the world.  A successful story of the modern society is leading the survival of the people into old age but in addition to these endocrine disorders this is becoming higly impossible. Endocrinology research has already begun to unlock the pathophysiology of these diseases  and will ultimately leads the prevention into treatment.  The market research showed that the global endocrine market will increase by more than 6% over CAGR. Increases in the prevalence of hormone related disorders such as hypogonadism, hyperthyroidism, hypothyroidism is one of the factors that is driving the market of endocrinology over the period of time. The prevalence of diabetes is on the rise owing to obesity, unhealthy diet, and lack of physical activity among individuals. According to many research studies, arround 415 million people were affected by diabetes in 2016 and this number is likely to reach 642 million by 2040. However with the growing disorders of endocrine system in men and women the intake of medications is likely to increase in the global market. Therefore the increase in the intake of the medications will increase the range of the market related to endocrine disorder in the global market in the next four years. Members of the American Association of Clinical Endocrinologists are working toward increasing public awareness and educating the people about diseases caused by the increase or decrease in the release of hormones. Also, Thyroid Awareness Month is organized in January every year, which is expected to spur the growth prospects for this market until the end of 2020.